A Novel Immunocompetent Preclinical Mouse Model to Uncover Oncogenic Initiators of Head and Neck Cancer
H. Kletzien,N.A. Nguyen,D.J. Anderson,A.J. Wagers
DOI: https://doi.org/10.1016/j.ijrobp.2024.01.168
IF: 8.013
2024-04-01
International Journal of Radiation Oncology*Biology*Physics
Abstract:Purpose/Objective(s) Mouse models of HNC have played an essential role in elucidating mechanisms driving tumor development and progression. However, the generation of new mouse models are extremely costly, laborious and time consuming, and are limited to the study of a few, and often “popular,” gene targets that do not fully recapitulate the intertumoral heterogeneity of HNCs. Using a novel preclinical model developed in our lab that involves the in vivo introduction of human-relevant HNC mutations by CRISPR-mediated gene editing, we aim to functionally interrogate and reveal molecular pathways and mechanisms driving tumor initiation and progression, and to test the highly intriguing, but as yet unproven, hypothesis that HNC initiation is driven by the acquisition and accumulation of mutations in somatic tissue stem cells and their progeny, a process of mutagenesis that may be influenced by sex and accelerated following carcinogen exposure. Materials/Methods Our data shows effective AAV transduction and targeted mutagenesis of multiple stem cell lineages (epithelial stem cells, mesenchymal stromal cells, and muscle stem cells) by numerous AAV serotypes after local AAV injection into the tongue, oral epithelium, pharynx/esophagus, and neck. Delivery of a custom AAV-CRISPR-library (10 sgRNAs/gene), targeting the 20 most frequently mutated genes in human HNCs, into male and female mice (n=32) conditionally expressing Cas9 in a lineage-selective manner, produced morphologically and anatomically distinct tumors that recapitulate the genetic heterogeneity and sex-variant emergence of human HNCs. Results Individual tumors show distinct combinations of missense (M), nonsense (N) and silent mutations in targeted genes that also are mutated in human HNCs (sample type [tumor vs PAT]: p<0.0001; mutation type [missense vs nonsense vs silent]: p<0.0001; anatomic location: p<0.0001) Molecular sequencing analysis from AAV-CRISPR-HNC tumors (n=29) reveal striking genetic diversity and high mutational burden that is reminiscent of human HNCs. Sequencing analysis from paired adjacent tissue (PAT; n=29) provides evidence of an intermediate precancerous state and field cancerization and points to a subset of the genetic targets in our custom library as particularly consequential for stem cell transformation in this model (gene, p<0.001; mutation type, p<0.001; anatomic location, p<0.001). Frameshift insertions/ deletions accounted for the majority of INDELS observed (>50%; p<0.0001), and further supports the use of our platform to introduce loss of function mutations in HNC tumors. Conclusion Taken together, our data suggests for the first time that somatic stem cells can serve as cells-of-origin for multiple, different HNC subtypes, and that HNCs may represent clonal diseases. Future applications of this innovative and translationally-oriented system will help to nominate new therapeutic targets and create a springboard for efforts to prevent and treat HNC.
oncology,radiology, nuclear medicine & medical imaging